Open-Label Study of AG10 in Patients With Cardiomyopathy (clinicaltrials.gov) - Oct 15, 2026 - P2 | N=47 | Terminated | Sponsor: Eidos Therapeutics, a BridgeBio company | Active, not recruiting ➔ Terminated; Study ended by the sponsor due to meeting Study Objectives
Trial termination • Cardiac Amyloidosis • Cardiomyopathy • Cardiovascular
|